Abstract:Nearly half of metastatic melanoma patients develop brain metastases (MBM). Local therapies like surgery and radiotherapy provide limited survival benefit. While targeted therapies and immune checkpoint inhibitors (ICI) improved outcomes in patients with asymptomatic MBM, the prognosis is still grim for the majority of patients. To decipher resistance mechanism to immunotherapy in MBM, we integrated datasets from both single-cell RNAseq (scRNAseq) and spatial transcriptomics (Visium). Our scRNAseq analysis of 25 MBM patients (7 treated pre-surgery with ICI) showed that lymphoid cells increased by 8.1-fold post-ICI (p=0.006). Notably, 34% of these were CXCL13+CXCR6+ putative tumor-reactive T cells (TR-T), known for their critical role as tumor-killing effectors. This led us to investigate why, despite their prevalence, TR-T don't translate to effective immunotherapy in MBM. Our scRNAseq interactome analysis revealed that ICI intensified IFN-II interactions between TR-T and interferon-stimulated macrophage/microglia (Mφ.ISG). However, it also boosted immunosuppressive interactions, like the TIGIT-NECTIN2 interaction, which increased 20 fold, potentially diminishing TR-T's effectiveness. To overcome the lack of spatial context in scRNAseq, we applied spatial transcriptomics on 27 MBM sections, including 12 post-ICI treatments. Remarkably, TR-T were primarily found (63%) in proximity with Mφ.ISG cells—not with tumor cells. These TR-T-Mφ.ISG niches were 1.7 times more prevalent in ICI-treated samples; these niches are rich in chemokine receptors like CCR1 and immunosuppressive molecules like NECTIN2. This suggests that Mφ.ISG cells are chemotactically attracted to TR-T, forming a barrier that impedes TR-T's tumor interaction and impairs their functionality. Our current efforts focus on pinpointing key pathways enriched within TR-T-Mφ.ISG niches, particularly in ICI-treated MBM. We are also assessing the clinical impact of these niches in relation to patient survival. Our goal is to elucidate how specific immunosuppressive subsets and molecules within the MBM microenvironment restrict TR-T effectiveness, with the ultimate objective of enhancing ICI efficacy for these patients.

Tmic-12. Litt Results In Robust T Cell Infiltration Within The Tumor Microenvironment In A Brain Metastasis Murine Model

Surg-48. Laser Interstitial Thermal Therapy Remodels The Tumor Immune Landscape In A Mouse Glioma Model

Murine Models of Laser Interstitial Thermal Therapy for Immuno-Oncology

LMD-03. Single Cell Analysis Reveals How Therapy Remodels the Tumor Microenvironment in Melanoma CNS Metastases and Uncovers a Novel Predictor of Improved Survival

Surg-49. Investigating Litt-Based Combination Therapies In Preclinical Glioma Models

Tmod-27. Recurrent Glioblastoma After Laser Ablation Of The Primary Tumor In A Preclinical Orthotopic Model Exhibit Increased Genetic Signatures Of Cell Cycle And Cell Motility

Establishment of C6 Brain Glioma Models Through Stereotactic Technique for Laser Interstitial Thermotherapy Research

Adaptation of laser interstitial thermal therapy for tumor ablation under MRI monitoring in a rat orthotopic model of glioblastoma

497 Superficial MRI-guided Laser Interstitial Thermal Therapy (LITT) for Intracranial Metastasis Is Associated With a Significantly Higher Rate of Leptomeningeal Disease

Localized ablative immunotherapy drives de novo CD8 + T-cell responses to poorly immunogenic tumors

Surg-06. Impact Of Laser Interstitial Thermal Therapy Versus Resection For Metastases Associated With The Motor Cortex

Laser interstitial thermal therapy in gliomas.

376 Laser Interstitial Thermal Therapy for Deep-Seated Perivascular Brain Tumors: Evaluating the Risk of Distal Ischemia

Efficacy of laser interstitial thermal therapy for biopsy-proven radiation necrosis in radiographically recurrent brain metastases

Contemporary Applications of Laser Interstitial Thermal Therapy: A Comprehensive Systematic Review

Tmic-78. Chemotherapy Induced Immunogenic Response In Glioma And Implications For Therapeutic Strategies

Laser interstitial thermal therapy in the treatment of brain metastases: the relationship between changes in postoperative magnetic resonance imaging characteristics and tumor recurrence

Tissue Temperature Distribution Measurement and Laser Immunotherapy for Cancer Treatment

The Impact of Perilesional Heatsink Structures on Ablation Volumes in Laser Interstitial Thermal Therapy for Brain Metastases

Combinatorial Checkpoint Blockade and Laser Interstitial Thermal Therapy: A Single Center Study

Tmic-81. An Immunosuppressive Macrophage Niche May Drive T Cell Dysfunction And Immunotherapy Resistance In Melanoma Brain Metastases